| Market Cap | ₹1,931Cr |
| ROE | 13.75% |
| P/E Ratio(TTM) | 18.12 |
| EPS(TTM) | 43.17 |
| P/B Ratio | 2.49 |
| Dividend Yield | 3.20% |
| Industry P/E | 40.10 |
| Book Value | 313.91 |
| Debt to Equity | 0.01 |
| Face Value | 5 |
| Parent Organisation | Novartis India Limited |
| Managing Director | Mr. Sanjay Murdeshwar |
| Founded | 1947 |
| BSE Symbol | 500672 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.42 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 31.89 | ||
| Wockhardt | NA (0.00%) | -459.97 | ||
| Cohance Lifesciences | NA (0.00%) | 65.93 |